Apigenin Ameliorates Dyslipidemia, Hepatic Steatosis and Insulin Resistance by Modulating Metabolic and Transcriptional Profiles in the Liver of High-Fat Diet-Induced Obese Mice

Several in vitro and in vivo studies have reported the anti-inflammatory, anti-diabetic and anti-obesity effects of the flavonoid apigenin. However, the long-term supplementary effects of low-dose apigenin on obesity are unclear. Therefore, we investigated the protective effects of apigenin against...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Un Ju, Cho, Yun-Young, Choi, Myung-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882717/
https://www.ncbi.nlm.nih.gov/pubmed/27213439
http://dx.doi.org/10.3390/nu8050305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882717/
https://www.ncbi.nlm.nih.gov/pubmed/27213439
http://dx.doi.org/10.3390/nu8050305

Ejemplares similares